Holdings
Parkman Healthcare Partners LLC
As of Sep 30, 2026, Parkman Healthcare Partners LLC reported 88 positions worth US$1.07B. Largest: PTC Therapeutics, Inc., Eli Lilly and Company and MBX Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| PTC Therapeutics, Inc. | 700K | US$45.4M | +265K | Sep 30, 2026 |
| Eli Lilly and Company | 38,119 | US$44.1M | +3,119 | Sep 30, 2026 |
| MBX Biosciences, Inc. | 717K | US$42M | −83,631 | Sep 30, 2026 |
| IQVIA Holdings, Inc. | 145K | US$39M | +39,410 | Sep 30, 2026 |
| DexCom, Inc. | 437K | US$37.7M | −97,733 | Sep 30, 2026 |
| Inhibrx Biosciences, Inc. | 360K | US$36.1M | +103K | Sep 30, 2026 |
| Viridian Therapeutics, Inc. | 1.67M | US$34.5M | +297K | Sep 30, 2026 |
| Scholar Rock Holding Corporation | 540K | US$26.1M | new | Sep 30, 2026 |
| CVS Health Corporation | 286K | US$24.5M | −106K | Sep 30, 2026 |
| Alto Neuroscience, Inc. | 949K | US$24.2M | +520K | Sep 30, 2026 |